Rongyu is a Ph.D. student in UW Bioengineering. She received her bachelor’s degree in Bioengineering from UCLA in 2017. She is currently working on new technologies to capture and analyze antigen-specific CD4+ T cells in cancer immunotherapy patients. Due to the COVID-19 pandemic, she is also working on associating antigen specificity of SARS-CoV-2 specific T cells with their phenotypes. Her work aims to understand which anti-viral T cell responses lead to immune-protection and how such responses can be anticipated, so as to inform vaccine design.
Bachelor of Science in Bioengineering (2013-2017), University of California, Los Angeles
Ph.D. student in Bioengineering (2018-current), University of Washington
Ph.D. candidate in the Heath lab (2019-current), Institute for Systems Biology
Protein engineering, cancer immunology, adaptive immunity in viral infection